×
About 16,875 results

ALLMedicine™ Congestive Heart Failure Center

Research & Reviews  4,588 results

Step-by-step typing for the accurate diagnosis of concurrent light chain and transthyre...
https://doi.org/10.1002/ehf2.13773
ESC Heart Failure; Moriyama H, Kitakata H et. al.

Jan 22nd, 2022 - While 99m Tc-pyrophosphate scintigraphy is clearly useful in diagnosing transthyretin amyloid cardiomyopathy (ATTR-CM), it is necessary to know the pitfalls of this test for proper use. We present a rare case of concurrent ATTR-CM and amyloid ligh...

Doxorubicin-Induced Cardiotoxicity: An Overview on Pre-clinical Therapeutic Approaches.
https://doi.org/10.1007/s12012-022-09721-1 10.2165/00003088-198815010-00002 10.7326/0003-4819-91-5-710 10.1001/jama.1991.03470120074036 10.1200/jco.2007.11.8877 10.1016/j.cpcardiol.2021.100994 10.1186/s13104-018-3260-6 10.1203/00006450-198704010-00127 10.1073/pnas.85.10.3585 10.1126/scitranslmed.3010189 10.1161/01.cir.0000160359.49478.c2 10.1016/j.jacbts.2016.10.006 10.1155/2012/619185 10.1038/cr.2010.178 10.1016/j.freeradbiomed.2014.03.001 10.3969/j.issn.1673-5374.2013.21.009 10.1007/s00280-009-0932-x 10.1146/annurev-pharmtox-011112-140320 10.1007/s00018-016-2223-0 10.1016/j.freeradbiomed.2015.05.028 10.1615/JEnvironPatholToxicolOncol.2019029341 10.1155/2020/5923572 10.2147/cmar.s186696 10.1007/s10787-019-00586-5 10.22038/ijbms.2019.33620.8020 10.1111/fcp.12590 10.18502/acta.v59i7.7020 10.1161/01.cir.91.1.10 10.1161/01.cir.89.6.2829 10.1155/2012/506214 10.1158/1078-0432.Ccr-07-1579 10.1161/CIRCULATIONAHA.108.799700 10.1007/s10557-020-06941-x 10.3390/molecules23051184 10.1038/cddis.2011.65 10.1016/j.biopha.2021.111708 10.1152/ajpheart.01047.2009 10.1161/jaha.119.012338 10.1016/s0022-2828(03)00229-3 10.3181/0706-RM-152 10.1038/srep45126 10.21037/cdt-19-707 10.1124/jpet.115.225375 10.1007/s11033-020-06095-x 10.1016/j.yebeh.2020.107343 10.3390/ijms19030757 10.1515/jbcpp-2018-0212 10.1016/j.ejphar.2010.05.046 10.3340/jkns.2018.0222 10.2174/1389201021666200422090952 10.1126/scitranslmed.aah5457 10.1016/j.celrep.2018.08.079 10.3389/fcvm.2020.00050 10.1038/srep25333 10.1038/nm.4087 10.1111/jcmm.14346 10.1038/srep44735 10.1038/s41420-019-0182-6 10.1073/pnas.1904979116 10.1186/1471-2407-14-842 10.3389/fcell.2020.00178 10.1016/j.cotox.2020.04.001 10.3389/fcvm.2021.774389
Cardiovascular Toxicology; Sheibani M, Azizi Y et. al.

Jan 22nd, 2022 - Doxorubicin is an effective chemotherapeutic agent prescribed to treat solid tumors (e.g., ovary, breast, and gastrointestinal cancers). This anti-cancer drug has various side effects, such as allergic reactions, cardiac damage, hair loss, bone ma...

Current use of inotropes according to initial blood pressure and peripheral perfusion i...
https://doi.org/10.1136/bmjopen-2021-053254
BMJ Open; Nagao K, Kato T et. al.

Jan 22nd, 2022 - Current guidelines restrict the use of inotropes for the treatment for heart failure (HF) unless the patients are hypotensive or hypoperfused because of safety concerns. This study sought to characterise the contemporary real-world use of inotrope...

The V-LAP System for Remote Left Atrial Pressure Monitoring of Patients with Heart Fail...
https://doi.org/10.1016/j.cardfail.2021.12.019
Journal of Cardiac Failure; Perl L, Meerkin D et. al.

Jan 19th, 2022 - Patients with heart failure (HF) are at an increased risk of hospital admissions. The aim of this report is to describe the feasibility, safety and accuracy of a novel wireless left atrial pressure (LAP) monitoring system in HF patients. The V-LAP...

Clinical and Molecular Characteristics of Primary Aldosteronism in Blacks
https://clinicaltrials.gov/ct2/show/NCT03374215

Jan 19th, 2022 - Primary Aldosteronism (PA) is the most common cause of secondary hypertension, accounting for 6-8% of hypertension and 14-25% of resistant hypertension. This prevalence translates to approximately 1 in 30-50 adults or about 4,000,000 Americans wit...

see more →

Guidelines  5 results

Appropriate Use of Point-of-Care Ultrasonography in Patients With Acute Dyspnea in Emer...
https://doi.org/10.7326/M20-7844
Annals of Internal Medicine; Qaseem A, Etxeandia-Ikobaltzeta I et. al.

Apr 27th, 2021 - The American College of Physicians (ACP) developed this guideline to provide clinical recommendations on the appropriate use of point-of-care ultrasonography (POCUS) in patients with acute dyspnea in emergency department (ED) or inpatient settings...

Seafood Long-Chain n-3 Polyunsaturated Fatty Acids and Cardiovascular Disease: A Scienc...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6903778
Circulation Rimm EB, Appel LJ et. al.

May 19th, 2018 - Since the 2002 American Heart Association scientific statement "Fish Consumption, Fish Oil, Omega-3 Fatty Acids, and Cardiovascular Disease," evidence from observational and experimental studies and from randomized controlled trials continues to e...

The vascular access in the elderly: a position statement of the Vascular Access Working...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5429362
Journal of Nephrology; Lomonte C, Forneris G et. al.

Jan 19th, 2016 - The incident hemodialysis (HD) population is aging, and the elderly group is the one with the most rapid increase. In this context it is important to define the factors associated with outcomes in elderly patients. The high prevalence of comorbidi...

Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stro...
https://doi.org/10.1016/j.cjca.2010.11.007
The Canadian Journal of Cardiology; Cairns JA, Connolly S et. al.

Feb 19th, 2011 - The stroke rate in atrial fibrillation is 4.5% per year, with death or permanent disability in over half. The risk of stroke varies from under 1% to over 20% per year, related to the risk factors of congestive heart failure, hypertension, age, dia...

NSAID prescribing precautions.
https://www.ncbi.nlm.nih.gov/pubmed/20000300
American Family Physician; Risser A, Donovan D et. al.

Dec 17th, 2009 - Nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly used, but have risks associated with their use, including significant upper gastrointestinal tract bleeding. Older persons, persons taking anticoagulants, and persons with a history of upp...

see more →

Drugs  797 results see all →

Clinicaltrials.gov  313 results

Dapagliflozin and Renal Surrogate Outcomes in Advanced Chronic Kidney Disease
https://clinicaltrials.gov/ct2/show/NCT05196347

Jan 19th, 2022 - Preamble Estimated glomerular filtration rate (eGFR) eGFR 30 mL/min/1.73m2 is a clinical cut point, below which advanced chronic kidney disease (CKD) (stage 4 and 5) is associated with a significantly increased risk of mortality and a 50-fold incr...

Clinical and Molecular Characteristics of Primary Aldosteronism in Blacks
https://clinicaltrials.gov/ct2/show/NCT03374215

Jan 19th, 2022 - Primary Aldosteronism (PA) is the most common cause of secondary hypertension, accounting for 6-8% of hypertension and 14-25% of resistant hypertension. This prevalence translates to approximately 1 in 30-50 adults or about 4,000,000 Americans wit...

Insulin Resistance Following ADT for Prostate CA
https://clinicaltrials.gov/ct2/show/NCT04658849

Jan 12th, 2022 - STUDY PLAN The Study will be conducted at Saint Louis University. The investigators plan to conduct a prospective, randomized, double-blind, placebo-controlled trial in 44 men with nonmetastatic prostate cancer who will receive ADT with long actin...

Effect of Olmesartan on Angiotensin(1-7) Levels and Vascular Functions in Diabetes and Hypertension
https://clinicaltrials.gov/ct2/show/NCT05189015

Jan 12th, 2022 - Both ACE inhibitor and ARB produce inhibition of the renin-angiotensin system, so clinicians have regarded ACE inhibitor and ARB as effectively equivalent, including blood pressure lowering, improvement of congestive heart failure symptoms, inhibi...

Lipidomics Screening of Anti-inflammatory Drugs and Drug Candidates in Vitro - Part A
https://clinicaltrials.gov/ct2/show/NCT02095288

Jan 11th, 2022 - Nonsteroidal anti-inflammatory drugs (NSAIDs), selective for inhibition of cyclooxygenase (COX)-2, alleviate pain and inflammation by suppressing COX-2-derived prostacyclin (PGI2) and prostaglandin (PG) E2 (1). However, eight placebo-controlled cl...

see more →

News  1,031 results

Orca-T Shows Impressive Clinical Outcomes in High-Risk Hematological Cancers
https://www.onclive.com/view/orca-t-shows-impressive-clinical-outcomes-in-high-risk-hematological-cancers

Jan 4th, 2022 - The high-precision allogeneic cellular therapy Orca-T significantly improved graft-vs-host disease (GVHD)–free relapse-free survival (RFS) and time to engraftment, significantly reduced acute and chronic GVHD, and showed a trend toward improved ov...

Smartphone App Could Give Voice to Congestion in Heart Failure
https://www.medscape.com/viewarticle/964913

Dec 15th, 2021 - Automated voice analysis using a proprietary smartphone app can detect pulmonary fluid overload with high accuracy in patients admitted with acute decompensated heart failure (ADHF), a new study suggests. Researchers envision the technique as a po...

Magrolimab Plus Various Anti-Leukemia Therapies Being Studied for Efficacy in AML
https://www.onclive.com/view/magrolimab-plus-various-anti-leukemia-therapies-being-studied-for-efficacy-in-aml

Dec 14th, 2021 - Magrolimab plus combinations of various anti-leukemia therapies are being investigated for efficacy as options for frontline, relapsed/refractory, or maintenance treatment of patients with acute myeloid leukemia (AML), according to a poster presen...

Darolutamide Plus Docetaxel/ADT Significantly Improves OS in Metastatic Hormone-Sensitive Prostate Cancer
https://www.onclive.com/view/darolutamide-plus-docetaxel-adt-significantly-improves-os-in-metastatic-hormone-sensitive-prostate-cancer

Dec 3rd, 2021 - The addition of darolutamide (Nubeqa) to docetaxel and androgen deprivation therapy (ADT) resulted in a significant improvement in overall survival (OS) compared with docetaxel/ADT alone in patients with metastatic hormone-sensitive prostate cance...

Simple Score Predicts Risk of Contrast-Associated Acute Kidney Injury After PCI
https://www.medscape.com/viewarticle/963706

Nov 29th, 2021 - NEW YORK (Reuters Health) - A risk score based on readily available variables from patients undergoing percutaneous coronary intervention (PCI) accurately predicted the risk of contrast-associated acute kidney injury (CA-AKI) in a modeling study. ...

see more →

Patient Education  16 results see all →